Pharmacokinetic study on echinocandins for patients with septic shock following secondary peritonitis

Pharmacokinetic study on echinocandins for patients with septic shock following secondary peritonitis - EPI Study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2016-002708-17-FR

Enrollment

Registered

2016-12-14

Start date

2016-11-25

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic shock following secondary peritonitis MedDRA version: 19.0 Level: LLT Classification code 10040580 Term: Shock septic System Organ Class: 100000004862 MedDRA version: 19.0 Level: LLT Classification code 10061135 Term: Spontaneous bacterial peritonitis System Organ Class: 100000004862

Interventions

Trade Name: CANCIDAS 50 mg poudre pour solution à diluer pour perfusion. Pharmaceutical Form: Powder for solution for infusion Trade Name: Mycamine 50 mg poudre pour solution pour perfusion Pharmaceu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 24 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactDirection de la recherche clinique

CHU DE NIMES

drc@chu-nimes.fr33466 68 68 36

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026